NEW YORK (Reuters Health) - In women with breast cancer, a radiation technique called intensity-modulated radiation therapy (IMRT) reduces the incidence of radiation-induced dermatitis, compared to conventional radiation, research shows.
About one third of breast cancer patients develop significant skin reactions after radiation therapy, often due to uneven distribution of radiation to the breast. Breast IMRT is a novel technique that delivers a more even dose of radiation throughout the breast relative to conventional radiation therapy. IMRT, unlike conventional radiation, tailors the dose of radiation to the three-dimensional shape of the tumor.
In a study of 170 women who had breast IMRT and 161 who had standard radiation therapy as part of a randomized trial, researchers observed that far fewer women in the breast IMRT arm than the standard radiation arm experienced scaling or peeling at the site of radiation.
Breast IMRT also led to a "dramatic improvement" in the distribution of radiation to the breast compared with standard radiotherapy, Dr. Jean-Philippe Pignol from Sunnybrook Health Sciences Centre, Toronto, Canada and colleagues report.
This improvement translated into a significant 17 percent absolute reduction in the frequency of scaling and peeling skin.
In a report of the study in the Journal of Clinical Oncology, Pignol and colleagues conclude that as breast IMRT becomes more widely available, it "should be offered" to women instead of conventional radiation therapy.
SOURCE: Journal of Clinical Oncology, May 1, 2008
The study reviewed here found that women who received radiation therapy using a special technique known as intensity-modulated radiation therapy (IMRT) were 17% less likely to develop scaling or peeling skin in the area exposed to radiation compared to women who got radiation therapy using traditional techniques. The researchers also found that IMRT was much better at delivering radiation to the intended treatment area and avoiding healthy tissue compared to traditional radiation therapy delivery techniques.
Skin reactions are common side effects of radiation therapy to treat breast cancer. If you have fair skin, it may look as if you have a slowly developing sunburn, with the skin gradually changing color to pink or red. If you have dark skin, this redness can be harder to see. Along with a color change, some women also may have other skin changes, such as:
Doctors have developed a number of new technologies and techniques to better target radiation therapy. These new techniques narrowly focus radiation on cancer cells and limit the exposure of healthy tissue (skin, heart, lungs) to radiation. Computers are used to precisely plan and deliver radiation therapy. IMRT uses a computer to precisely deliver multiple concentrated beams of radiation to a three-dimensional target area of breast tissue. This precision limits unnecessary exposure of skin and other healthy tissue to radiation that may have happened when radiation was delivered using older techniques. Other new technology gives your radiation oncologist more and safer choices of radiation energy sources.
Still, IMRT isn't for everyone. Other new radiation therapy techniques may be better options for many women. If radiation therapy is part of your breast cancer treatment plan, talk to your radiation oncologist about which radiation therapy techniques make sense for your unique situation. Together you and your doctor can decide on the approach that is best for you.
Visit the Breastcancer.org Radiation Therapy section to learn more about how radiation therapy works, how it's given, possible side effects, and how to manage any side effects you might have.
Breastcancer.org 7 East Lancaster Avenue, 3rd Floor Ardmore, PA 19003
Learn more about our commitment to your privacy
© 2008 Breastcancer.org - All rights reserved.
Breastcancer.org is a non-profit organization dedicated to providing information and community to those touched by this disease. Learn more about our commitment to providing complete, accurate, and private breast cancer information.